Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab

Autor:	Abbadessa, G, Miele, G, Cavalla, P, Valentino, P, Marfia, Ga, Vercellino, M, De Martino, A, Simeon, V, Lavorgna, L, Bonavita, S
Rok vydání:	2023
Předmět:	Multiple sclerosis Neurology Disease modifying therapies Immunology Immunology and Allergy Ocrelizumab Switch Neurology (clinical) Treatment response Settore MED/26
Zdroj:	Journal of Neuroimmunology. 378:578072
ISSN:	0165-5728
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70686e9d85592a786f4f27c2146d490 https://doi.org/10.1016/j.jneuroim.2023.578072 Zobrazit plný text záznamu Full Text from ScienceDirect